WideTrial Supports NIH-Funded Expanded Access Program for Investigational ALS Drug ...Middle East

Program to provide investigational drug to ALS patients who would otherwise be ineligible for clinical trials SANTA CLARA, Calif., Nov. 20, 2024 /PRNewswire/ -- WideTrial, an innovator of expanded access program (EAP) solutions, announced its participation in an NIH-funded collaboration...

Read More Details
Finally We wish PressBee provided you with enough information of ( WideTrial Supports NIH-Funded Expanded Access Program for Investigational ALS Drug )

Also on site :

• HR Path étend sa présence avec l'acquisition de smahrt consulting AG en Suisse, spécialiste du conseil, de l'intégration et de l'externalisation dans le domaine des ressources humaines et des systèmes d'information.
• HSBC first-quarter profit tops expectations, drops 25% from a year earlier
• Inside Trump’s Hardball Strategy to Control Global Oil Prices